170 Operative Management of Adult Spinal Deformity Results in Significant Increases in QALYs Gained Compared With Nonoperative Management: Analysis of 479 Patients With Minimum 2-Year Follow-up

INTRODUCTION:Operative management of adult spinal deformity (ASD) repeatedly demonstrates improvements in health-related quality of life over nonoperative treatment. However, little is reported regarding the quality-adjusted life-year (QALY) improvements following surgical correction of ASD. The pur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosurgery 2015-08, Vol.62 Suppl 1, CLINICAL NEUROSURGERY (Supplement 1), p.222-222
Hauptverfasser: Scheer, Justin K, Hostin, Richard A, Schwab, Frank, Robinson, Chessie, Lafage, Virginie, Burton, Douglas C, Hart, Robert, Kelly, Michael P, Keefe, Malla, Polly, David W, Bess, Shay, Shaffrey, Christopher I, Smith, Justin S, Ames, Christopher P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:INTRODUCTION:Operative management of adult spinal deformity (ASD) repeatedly demonstrates improvements in health-related quality of life over nonoperative treatment. However, little is reported regarding the quality-adjusted life-year (QALY) improvements following surgical correction of ASD. The purpose of this study was to evaluate the QALY increases following the operative treatment of ASD compared with nonoperative treatment. METHODS:Inclusion criteria=18 years, ASD. Health utility values were calculated from SF-6D scores and used to calculate QALYs gained or lost at a minimum 2 years from the baseline utility value. A subanalysis was conducted on the available patients in the cohort with complete 1-, 2-, and 3-year SF-36 scores to establish a trend in QALY changes. RESULTS:Three hundred sixty-five operative (OP) and 469 nonoperative (NONOP) patients were eligible for 2-year follow-up, and 479 patients were included (OP258 (70.7%), NONOP221 (47.1%). OP had significantly worse health utility values (0.545 ± 0.118 vs 0.657 ± 0.114, P < .0001), and larger QALY gained (0.139 ± 0.253 vs −0.004 ± 0.209, P < .0001). OP had lower QALY at minimum 2 years (1.28 ± 0.330 vs 1.39 ± 0.374, P = .0014). One hundred seventy-nine patients (OP106, NONOP73) had complete 1-, 2-, and 3-year SF-36 scores and were included in the subanalysis. Of these patients, both groups had statistically similar mean QALYs at all time points (OP vs NONOP, P > .05)1 year (0.648 ± 0.102 vs 0.645 ± 0.090), 2 year (1.32 ± 0.232 vs 1.27 ± 0.204), and 3 year (1.97 ± 0.379 vs 1.93 ± 0.303). OP patients had a significantly larger increase in QALYs (from baseline) at 1, 2, and 3 years compared with NONOP (Figure)1 year (0.084 ± 0.113 vs 0.011 ± 0.086, P < .0001), 2 year (0.179 ± 0.240 vs 0.005 ± 0.186, P < .0001), and 3 year (0.258 ± 0.354 vs 0.020 ± 0.258, P < .0001). CONCLUSION:The operative treatment of ASD results in significant increases in QALYs gained at minimum 2 years postoperatively as well as at the 1-, 2-, and 3-year time points compared with nonoperative management.
ISSN:0148-396X
1524-4040
DOI:10.1227/01.neu.0000467134.43267.d9